He has been involved in enrolling more than 700 patients in more than a dozen studies at the NIH Clinical Center and has co-authored 82 published peer-reviewed manuscripts addressing biochemical mechanisms involved in blood vessel relaxation and contracti www.strategicresults.com/ph/gladwin.html
Senior Investigator Dr. Mark Gladwin leads the Sickle Cell/Nitric Oxide Therapeutic Section in the Critical Care Medicine Department at the NIH Clinical Center. www.cc.nih.gov/about/news/mfp/mfp03/bios03/gladwin.shtml
Biosketch Dr. Mark Gladwin is both a senior investigator with the Critical Care Medicine Department at the NIH Clinical Center and the chief of the Vascular Medicine Branch at NIHs National, Heart, Lung, and Blood Institute. www.cc.nih.gov/about/SeniorStaff/mark_gladwin.html
Search, view, and download campaign finance reports and data available from the Federal Election Commission on the campaign finance activities of Federal election candidates... query.nictusa.com/cgi-bin/ind_detail/GLADWIN|MARK|WASHING...
An Expert Interview With Mark Gladwin, MD -- Part 2: PAH and Sickle Cell Disease The incidence of PAH in patients with sickle cell disease may be as high as 32%. www.worldglobe4.info/Disease.htm
Workshop on 29th Annual Meeting of the National Sickle Cell Disease Program co-sponsored by the Office of Rare Diseases at NIH rarediseases.info.nih.gov/html/workshops/workshops/sickle...